Related Experiment Videos
Aspirin and colorectal cancer
C La Vecchia1, E Negri, S Franceschi
1Istituto di Ricerche Farmacologiche Mario Negri, Milan, Italy.
British Journal of Cancer
|January 1, 1997
Summary
Regular aspirin use was associated with a reduced risk of colorectal cancer in an Italian case-control study. The findings suggest a potential protective effect of aspirin against this common cancer.
Area of Science:
- Epidemiology
- Oncology
- Gastroenterology
Background:
- Colorectal cancer (CRC) is a significant global health concern.
- Aspirin, a common non-steroidal anti-inflammatory drug (NSAID), has been investigated for its potential role in cancer prevention.
Purpose of the Study:
- To investigate the association between regular aspirin consumption and the risk of developing colorectal cancer.
- To quantify the odds ratio for colorectal cancer among regular aspirin users compared to non-users.
Main Methods:
- A case-control study design was employed in Italy.
- Data on regular aspirin use were collected from colorectal cancer cases and control subjects.
- Multivariate analysis was conducted, adjusting for education, physical activity, and dietary factors.
Main Results:
- Regular aspirin use was reported by 3.5% of cases and 4.1% of controls.
- The multivariate odds ratio (OR) for colorectal cancer associated with regular aspirin use was 0.7 (95% Confidence Interval [CI] 0.5-1.0).
- This suggests a potential, though not statistically significant at conventional levels, reduction in risk.
Conclusions:
- The study indicates a possible inverse relationship between regular aspirin use and colorectal cancer risk in the studied Italian population.
- Further research is warranted to confirm these findings and elucidate the underlying mechanisms.